Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,900.00    26.00 (0.67%)
Bid:
3,902.00
Ask:
3,906.00
Spread: 4.00 (0.103%)
Market Cap: £14.73b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report
14th Jun 20167:00 amRNSFinal Results
1st Jun 20162:21 pmRNSTotal Voting Rights
31st May 20164:15 pmRNSNotice of Results
3rd May 20162:22 pmRNSTotal Voting Rights
8th Apr 20162:22 pmRNSDirector Declaration
1st Apr 20163:37 pmRNSTotal Voting Rights
1st Mar 20164:58 pmRNSTotal Voting Rights
25th Feb 20165:13 pmRNSHome Member State
16th Feb 20164:21 pmRNSDirector/PDMR Shareholding
11th Feb 20167:00 amRNSTrading Update
5th Feb 20167:00 amRNSAcquisition
1st Feb 201612:27 pmRNSTotal Voting Rights
19th Jan 20162:31 pmRNSPDMR Shareholding
4th Jan 20162:30 pmRNSTotal Voting Rights
17th Dec 20157:00 amRNSAcquisition of Visiometrics
1st Dec 20154:28 pmRNSTotal Voting Rights
18th Nov 20151:12 pmRNSDirectorate Change
18th Nov 20151:01 pmRNSDoc re. Half Yearly Report
17th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20154:26 pmRNSNotice of Half Year Results and Dividend
2nd Nov 201512:47 pmRNSTotal Voting Rights
6th Oct 20157:00 amRNSAcquisition
5th Oct 201511:03 amRNSDirector/PDMR Shareholding
1st Oct 20156:15 pmRNSTotal Voting Rights
17th Sep 201510:00 amRNSInvestor Event
1st Sep 20154:14 pmRNSHolding(s) in Company
1st Sep 20152:48 pmRNSTotal Voting Rights
26th Aug 201510:53 amRNSDirector/PDMR Shareholding
11th Aug 20155:11 pmRNSDirector/PDMR Shareholding - Replacement
11th Aug 20152:38 pmRNSDirector/PDMR Shareholding
3rd Aug 20151:26 pmRNSDirector/PDMR Shareholding
3rd Aug 201512:33 pmRNSTotal Voting Rights
24th Jul 201510:06 amRNSDirectorate Change
23rd Jul 20155:33 pmRNSResult of AGM
23rd Jul 20157:00 amRNSAGM Trading Update
3rd Jul 201510:46 amRNSBlocklisting Interim Review
1st Jul 20152:19 pmRNSTotal Voting Rights
30th Jun 20154:56 pmRNSDirector Declaration
23rd Jun 201510:49 amRNSAnnual Financial Report
11th Jun 20157:00 amRNSFinal Results
1st Jun 201510:49 amRNSTotal Voting Rights
26th May 201512:18 pmRNSNotice of Results
15th May 20159:00 amRNSDirectorate Change
1st May 201511:10 amRNSTotal Voting Rights
28th Apr 20152:09 pmRNSHolding(s) in Company
2nd Apr 20151:00 pmRNSDirectorate Change
1st Apr 20154:50 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.